Nuclear Phase Separation Drives NPM1-mutant Acute Myeloid Leukemia.

Area of Science:

• Molecular Biology
• Cancer Biology
• Biochemistry

Background:

• Aberrant HOXA gene expression is a hallmark of leukemia, often driven by genetic alterations.
• The convergence of various mutations on HOXA gene regulation in leukemia remains unclear.

Purpose of the Study:

• To investigate the molecular mechanisms by which mutations in NPM1, nucleoporin genes, and KMT2A converge on HOXA gene regulation in leukemia.
• To identify and characterize novel regulatory structures involved in leukemogenesis.

Main Methods:

• Utilized human cell lines, mouse models, and primary patient samples.
• Employed mutagenesis and pharmacological approaches to study phase separation.
• Analyzed gene expression, protein recruitment, and cellular phenotypes.

Main Results:

• Mutant NPM1 (NPM1c) forms nuclear condensates, a process critical for recruiting NUP98 and KMT2A.
• NPM1c condensates are essential for regulating gene expression, promoting leukemic cell expansion, and maintaining the undifferentiated state.
• Fusion proteins involving nucleoporins and KMT2A also form similar condensates.

Conclusions:

• Defined a novel nuclear condensate, termed coordinating bodies (C-bodies), as a key player in leukemia.
• Established C-bodies as a convergence point for disparate mutations driving leukemogenesis.
• Proposed C-bodies as a potential therapeutic vulnerability for leukemia treatment.